BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• BioCapital

  Innovative Cellular Therapeutics (ICT) Presented Data at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting

  Innovative Cellular Therapeutics, Inc. (ICT) today announced the Company presented at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual meeting in Los Angeles, California. May 16-20, 2023.

  May 24, 2023

   · 

  2 min read
• Business

  Rani Therapeutics Appoints Kate McKinley as Chief Business Officer

  Rani Therapeutics Holdings, Inc. today announced that it has appointed Kate McKinley as its Chief Business Officer.

  May 24, 2023

   · 

  4 min read
• Genetown

  Ikena Oncology to Participate in Upcoming Investor Conferences

  Ikena Oncology, Inc. today announced that management will participate in TD Cowen’s 4th Annual Oncology Innovation Summit taking place May 30-31, 2023, and the Jefferies Healthcare Conference taking place June 7-9, 2023.

  May 24, 2023

   · 

  4 min read
• Drug Development

  Eloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal Trial for the Treatment of Alport Syndrome with Nonsense Mutations Following Achievement of Remission in Patient in Phase 2 Study

  Eloxx Pharmaceuticals, Inc. today announced that the company intends to advance ELX-02 into a pivotal trial for the treatment of Alport syndrome with nonsense mutations, following the achievement of remission in one patient in its Phase 2 clinical study.

  May 24, 2023

   · 

  7 min read
• Business

  Biorem Reports First Quarter Financial Results - May 24, 2023

  BIOREM Inc. today announced results for the three month period ended March 31, 2023.

  May 24, 2023

   · 

  3 min read
• Biotech Bay

  Ionpath Announces Shift Toward Spatial Proteomics Services Business

  Ionpath, a pioneer in high-definition spatial proteomics, announced a rebalancing of the company’s focus toward its Spatial Proteomics Services.

  May 24, 2023

   · 

  2 min read
• Biotech Bay

  Twist Bioscience to Present at Upcoming Investor Conferences - May 24, 2023

  Twist Bioscience Corporation today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Jim Thorburn, CFO of Twist Bioscience, will present at the following upcoming investor conferences.

  May 24, 2023

   · 

  1 min read
• Business

  Sinaptica Appoints Ken Mariash as Chief Executive Officer

  Sinaptica Therapeutics, Inc announces the appointment of Ken Mariash Jr. as Chief Executive Officer.

  May 24, 2023

   · 

  6 min read
• Business

  Poolbeg Pharma PLC Announces Board Appointment - May 24, 2023

  Poolbeg Pharma announces the appointment of Brendan Buckley as an Independent Non-Executive Director of the Company with immediate effect.

  May 24, 2023

   · 

  5 min read
• Pharm Country

  West to Participate in Upcoming Investor Conferences - May 24, 2023

  West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that it will present at the William Blair 43rd Annual Growth Stock Conference in Chicago, IL on Tuesday, June 6, 2023 at 1:20pm CT.

  May 24, 2023

   · 

  1 min read